AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 15606222 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous ceftriaxone 1g and intravenous azithromycin 500 mg daily
Number of subjects: 212
Study 15606222 — intervention group
Group type: COMPARATOR
Intervention: Intravenous levofloxacin 500 mg daily
Number of subjects: 212
Study 14752875 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical therapy intervention (five sessions of physical therapy and an individualized home exercise program)
Number of subjects: 28
Study 10424316 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril 12.5 mg
Number of subjects: 0
Study 10424316 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril 25 mg
Number of subjects: 0
Study 10424316 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril 5 mg
Number of subjects: 0
Study 10424316 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril 10 mg
Number of subjects: 0
Study 10424316 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 7481947 — intervention group
Group type: EXPERIMENTAL
Intervention: Exclusive breastfeeding (EBF)
Number of subjects: 0
Study 7481947 — intervention group
Group type: COMPARATOR
Intervention: Breastfeeding with supplementary foods (BF+SF)
Number of subjects: 0
Study 2283608 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrosurgical needle incision
Number of subjects: 0
Study 2283608 — intervention group
Group type: COMPARATOR
Intervention: Conventional scalpel incision
Number of subjects: 0
Study 6786730 — intervention group
Group type: EXPERIMENTAL
Intervention: Protective environment with prophylactic oral nonabsorbable antibiotics
Number of subjects: 95
Study 6786730 — intervention group
Group type: COMPARATOR
Intervention: Open ward care
Number of subjects: 95
Study 30886898 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide combined with noninvasive mechanical ventilation (10 days treatment)
Number of subjects: 82
Study 30886898 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide combined with noninvasive mechanical ventilation
Number of subjects: 82
Study 30886898 — intervention group
Group type: COMPARATOR
Intervention: Noninvasive mechanical ventilation
Number of subjects: 82
Study 28146658 — intervention group
Group type: EXPERIMENTAL
Intervention: Bicalutamide (150 mg daily for 24 months)
Number of subjects: 760
Study 28146658 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 760
Study 25957224 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel-aspirin therapy (loading dose of 300 mg of clopidogrel on day 1, followed by 75 mg of clopidogrel per day for 90 days, plus 75 mg of aspirin per day for the first 21 days)
Number of subjects: 5170
Study 25957224 — intervention group
Group type: COMPARATOR
Intervention: Aspirin alone (75 mg/d for 90 days)
Number of subjects: 5170
Study 25957224 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel-aspirin therapy
Number of subjects: 5170
Study 25957224 — intervention group
Group type: COMPARATOR
Intervention: Aspirin alone
Number of subjects: 5170
Study 24077452 — intervention group
Group type: COMPARATOR
Intervention: Bevacizumab
Number of subjects: 0
Study 24077452 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab-plus-pemetrexed
Number of subjects: 0
Study 21419306 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous ultrasonic irrigation (CUI)
Number of subjects: 20
Study 21419306 — intervention group
Group type: COMPARATOR
Intervention: Side‐vented needle irrigation (SNI)
Number of subjects: 20
Study 21419306 — intervention group
Group type: EXPERIMENTAL
Intervention: Both techniques (CUI and SNI)
Number of subjects: 20
Study 19272750 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive interpretational Cognitive Bias Modification (CBM‐I)
Number of subjects: 34
Study 19272750 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 34
Study 17251510 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic cheese (50 g daily)
Number of subjects: 276
Study 17251510 — intervention group
Group type: COMPARATOR
Intervention: Control cheese (50 g daily)
Number of subjects: 276
Study 15823764 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxycodone 5 mg/ibuprofen 400 mg
Number of subjects: 498
Study 15823764 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen 400 mg
Number of subjects: 498
Study 15823764 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxycodone 5 mg
Number of subjects: 498
Study 15823764 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 498
Study 11525072 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical exercise program for eight months, with an intensity of 60% to 80% of heart rate reserve, consisting of three weekly sessions of 60 minutes each.
Number of subjects: 63
Study 11525072 — intervention group
Group type: COMPARATOR
Intervention: Control group maintained normal activity.
Number of subjects: 63
Study 9489588 — intervention group
Group type: EXPERIMENTAL
Intervention: u-hFSH
Number of subjects: 134
Study 9489588 — intervention group
Group type: EXPERIMENTAL
Intervention: r-hFSH
Number of subjects: 134
Study 9489588 — intervention group
Group type: EXPERIMENTAL
Intervention: r-hFSH (i.v.)
Number of subjects: 134
Study 9489588 — intervention group
Group type: EXPERIMENTAL
Intervention: u-hFSH (i.v.)
Number of subjects: 134
Study 9489588 — intervention group
Group type: EXPERIMENTAL
Intervention: r-hFSH (i.m. and s.c.)
Number of subjects: 134
Study 9489588 — intervention group
Group type: EXPERIMENTAL
Intervention: u-hFSH (i.m. and s.c.)
Number of subjects: 134
Study 9489588 — intervention group
Group type: EXPERIMENTAL
Intervention: r-hFSH and u-hFSH
Number of subjects: 134
Study 7836206 — intervention group
Group type: EXPERIMENTAL
Intervention: Handgrip training
Number of subjects: 17
Study 7836206 — intervention group
Group type: COMPARATOR
Intervention: Control (no training)
Number of subjects: 17
Study 31677386 — intervention group
Group type: EXPERIMENTAL
Intervention: BCG-Denmark
Number of subjects: 2851
Study 31677386 — intervention group
Group type: COMPARATOR
Intervention: BCG-Russia
Number of subjects: 2851
Study 31677386 — intervention group
Group type: EXPERIMENTAL
Intervention: BCG-Japan
Number of subjects: 2851
Study 29198593 — intervention group
Group type: EXPERIMENTAL
Intervention: asymmetric CTA membranes
Number of subjects: 16
Study 26440690 — intervention group
Group type: EXPERIMENTAL
Intervention: Alexis O cesarean delivery retractor
Number of subjects: 301
Study 26440690 — intervention group
Group type: COMPARATOR
Intervention: Conventional handheld retractors
Number of subjects: 301
Study 24052416 — intervention group
Group type: EXPERIMENTAL
Intervention: MICA-TKA (Minimally Invasive and Computer-Assisted Total Knee Arthroplasty)
Number of subjects: 87
Study 24052416 — intervention group
Group type: COMPARATOR
Intervention: C-TKA (Conventional Total Knee Arthroplasty)
Number of subjects: 87
Study 22634964 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute bicarbonate (0.3 g/kg BM)
Number of subjects: 7
Study 22634964 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic bicarbonate (0.5 g/kg BM daily for 3 days)
Number of subjects: 7
Study 22634964 — intervention group
Group type: COMPARATOR
Intervention: Calcium carbonate placebo
Number of subjects: 7
Study 20022032 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptive spaced education system
Number of subjects: 62
Study 20022032 — intervention group
Group type: COMPARATOR
Intervention: Nonadaptive spaced education system
Number of subjects: 62
Study 19246266 — intervention group
Group type: EXPERIMENTAL
Intervention: Stapled hemorrhoidopexy (SH)
Number of subjects: 1276
Study 19246266 — intervention group
Group type: COMPARATOR
Intervention: Milligan‐Morgan hemorrhoidectomy (MMH)
Number of subjects: 1276
Study 19246266 — intervention group
Group type: EXPERIMENTAL
Intervention: Ligasure hemorrhoidectomy
Number of subjects: 1276
Study 19246266 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemorrhoidal artery ligation procedure
Number of subjects: 1276
Study 19246266 — intervention group
Group type: COMPARATOR
Intervention: Conventional excisional surgery
Number of subjects: 1276
Study 17021352 — intervention group
Group type: EXPERIMENTAL
Intervention: sunscreen
Number of subjects: 143
Study 17021352 — intervention group
Group type: COMPARATOR
Intervention: no sunscreen
Number of subjects: 143
Study 17021352 — intervention group
Group type: EXPERIMENTAL
Intervention: sun damage
Number of subjects: 143
Study 17021352 — intervention group
Group type: EXPERIMENTAL
Intervention: sun damage plus AK
Number of subjects: 143
Study 17021352 — intervention group
Group type: EXPERIMENTAL
Intervention: early AK
Number of subjects: 143
Study 17021352 — intervention group
Group type: EXPERIMENTAL
Intervention: AK
Number of subjects: 143
Study 12727038 — intervention group
Group type: EXPERIMENTAL
Intervention: Prompt Sheet (PS)
Number of subjects: 60
Study 12727038 — intervention group
Group type: COMPARATOR
Intervention: General Information Sheet (GI)
Number of subjects: 60
Study 11064622 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl
Number of subjects: 12
Study 11064622 — intervention group
Group type: EXPERIMENTAL
Intervention: Sufentanil
Number of subjects: 12
Study 11064622 — intervention group
Group type: COMPARATOR
Intervention: Bupivacaine with fentanyl
Number of subjects: 12
Study 11064622 — intervention group
Group type: COMPARATOR
Intervention: Bupivacaine with sufentanil
Number of subjects: 12
Study 11064622 — intervention group
Group type: COMPARATOR
Intervention: Epidural PCA with fentanyl
Number of subjects: 12
Study 11064622 — intervention group
Group type: COMPARATOR
Intervention: Epidural PCA with sufentanil
Number of subjects: 12
Study 8736566 — intervention group
Group type: EXPERIMENTAL
Intervention: Verbal memory assessment in older subjects
Number of subjects: 0
Study 8736566 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonverbal memory assessment in older subjects
Number of subjects: 0
Study 8736566 — intervention group
Group type: COMPARATOR
Intervention: Comparison with younger subjects
Number of subjects: 0
Study 8736566 — intervention group
Group type: COMPARATOR
Intervention: Comparison with older subjects
Number of subjects: 0
Study 1410168 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal nicotine spray (2 mg nicotine base, mean 27.8 micrograms/kg)
Number of subjects: 10
Study 1410168 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal nicotine spray
Number of subjects: 10
Study 1410168 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal nicotine spray (ad libitum use)
Number of subjects: 10
Study 2581913 — intervention group
Group type: EXPERIMENTAL
Intervention: Serocytol "Muqueuse urinaire"
Number of subjects: 24
Study 2581913 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 31305874 — intervention group
Group type: EXPERIMENTAL
Intervention: Nabiximols (up to 32 sprays daily, containing 86.4 mg tetrahydrocannabinol and 80 mg cannabidiol)
Number of subjects: 128
Study 31305874 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 128
Study 31305874 — intervention group
Group type: COMPARATOR
Intervention: Nabiximols and Placebo (both groups)
Number of subjects: 128
Study 31305874 — intervention group
Group type: EXPERIMENTAL
Intervention: Nabiximols
Number of subjects: 128
Study 28899206 — intervention group
Group type: EXPERIMENTAL
Intervention: Augmented acupuncture (LI4, LIV3, EX-HN3, GV20, LU7, KID6, including intradermal needles for sustained treatment)
Number of subjects: 140
Study 28899206 — intervention group
Group type: COMPARATOR
Intervention: Standard acupuncture (LI4, LIV3, EX-HN3, GV20)
Number of subjects: 140
Study 27418034 — intervention group
Group type: EXPERIMENTAL
Intervention: Fortified cereal (50 g) with 150 ml semi-skimmed milk, consumed daily for 12 weeks
Number of subjects: 71
Study 27418034 — intervention group
Group type: COMPARATOR
Intervention: Unfortified cereal (50 g) with 150 ml semi-skimmed milk, consumed daily for 12 weeks
Number of subjects: 71
Study 27418034 — intervention group
Group type: EXPERIMENTAL
Intervention: Fortified cereal (50 g) with 150 ml semi-skimmed milk
Number of subjects: 71
Study 24574869 — intervention group
Group type: EXPERIMENTAL
Intervention: Bitewing radiographs (BW)
Number of subjects: 363
Study 22699751 — intervention group
Group type: EXPERIMENTAL
Intervention: Lutein (10 mg daily for up to 3 months)
Number of subjects: 22
Study 22699751 — intervention group
Group type: COMPARATOR
Intervention: Zeaxanthin (10 mg daily for up to 3 months)
Number of subjects: 22
Study 20070745 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate implant placement
Number of subjects: 93
Study 17592923 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 554
Study 17592923 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 554
Study 17592923 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of PME at baseline
Number of subjects: 554
Study 17592923 — intervention group
Group type: COMPARATOR
Intervention: Worsening
Number of subjects: 554
Study 15652164 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified potassium citrate toothpaste with triclosan and zinc citrate (Test)
Number of subjects: 56
Study 15652164 — intervention group
Group type: COMPARATOR
Intervention: Existing potassium citrate toothpaste product (Positive Control)
Number of subjects: 56
Study 11858916 — intervention group
Group type: EXPERIMENTAL
Intervention: Heliox-driven continuous nebulizers (70:30 heliox)
Number of subjects: 36
Study 11858916 — intervention group
Group type: COMPARATOR
Intervention: Air with 30% O(2) (control group)
Number of subjects: 36
Study 9527746 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual Roller Pump (MRP)
Number of subjects: 30
Study 9527746 — intervention group
Group type: COMPARATOR
Intervention: Pressure Infusor Pump (PIP)
Number of subjects: 30
Study 9527746 — intervention group
Group type: EXPERIMENTAL
Intervention: Both pumps
Number of subjects: 30
Study 7888516 — intervention group
Group type: EXPERIMENTAL
Intervention: Nalbuphine 10 mg
Number of subjects: 100
Study 7888516 — intervention group
Group type: COMPARATOR
Intervention: Meperidine 25 mg
Number of subjects: 100
Study 2145718 — intervention group
Group type: EXPERIMENTAL
Intervention: Subunit plasma vaccine against hepatitis B, administered in three injections.
Number of subjects: 1000
Study 2145718 — intervention group
Group type: COMPARATOR
Intervention: Control group (no vaccination).
Number of subjects: 1000
Study 668779 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 31567592 — intervention group
Group type: EXPERIMENTAL
Intervention: Saline MDNTP‐US technique
Number of subjects: 96
Study 31567592 — intervention group
Group type: COMPARATOR
Intervention: MDNTP‐US technique
Number of subjects: 96
Study 31601989 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram based on prognostic factors (open operation, COPD, intra-operative blood transfusion, tumor location, longer operation time)
Number of subjects: 2469
Study 31601989 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram predictions
Number of subjects: 2469
Study 31601989 — intervention group
Group type: EXPERIMENTAL
Intervention: Calibration curves
Number of subjects: 2469
Study 28584075 — intervention group
Group type: EXPERIMENTAL
Intervention: Zone model predictive control (AP) system
Number of subjects: 19
Study 28584075 — intervention group
Group type: COMPARATOR
Intervention: Sensor augmented pump (SAP) therapy
Number of subjects: 19
Study 25041849 — intervention group
Group type: EXPERIMENTAL
Intervention: NBI-TUR
Number of subjects: 254
Study 25041849 — intervention group
Group type: COMPARATOR
Intervention: WLI-TUR
Number of subjects: 254
Study 24359765 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrographic LVH (ECG-LVH) diagnosis by strain pattern or Cornell voltage >2.0 mV (women) or >2.4 mV (men)
Number of subjects: 303
Study 24359765 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrographic LVH (ECG-LVH) diagnosis
Number of subjects: 303
Study 21084154 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydralazine
Number of subjects: 16
Study 21084154 — intervention group
Group type: COMPARATOR
Intervention: Labetalol
Number of subjects: 16
Study 18768293 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 16
Study 18768293 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 17552957 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolterodine extended-release (ER)
Number of subjects: 1015
Study 17552957 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1015
Study 15228994 — intervention group
Group type: EXPERIMENTAL
Intervention: Amniotic Fluid Index (AFI)
Number of subjects: 537
Study 15228994 — intervention group
Group type: COMPARATOR
Intervention: Single Deepest Pocket Technique
Number of subjects: 537
Study 12169332 — intervention group
Group type: EXPERIMENTAL
Intervention: CLN5 patients
Number of subjects: 5
Study 12169332 — intervention group
Group type: COMPARATOR
Intervention: Healthy age‐matched controls
Number of subjects: 5
Study 9666940 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.025 mg/day transdermal 17 beta‐estradiol
Number of subjects: 91
Study 9666940 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.05 mg/day transdermal 17 beta‐estradiol
Number of subjects: 91
Study 9666940 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1 mg/day transdermal 17 beta‐estradiol
Number of subjects: 91
Study 9666940 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 91
Study 7867109 — intervention group
Group type: EXPERIMENTAL
Intervention: alfentanil 250 micrograms with midazolam approximately 50 micrograms.kg‐1 (Group M)
Number of subjects: 60
Study 7867109 — intervention group
Group type: COMPARATOR
Intervention: meperidine 50 mg with diazepam approximately 90 micrograms.kg‐1 (Group D)
Number of subjects: 60
Study 7867109 — intervention group
Group type: EXPERIMENTAL
Intervention: Not applicable
Number of subjects: 60
Study 2744064 — intervention group
Group type: EXPERIMENTAL
Intervention: zopiclone 7.5 mg
Number of subjects: 60
Study 2744064 — intervention group
Group type: EXPERIMENTAL
Intervention: temazepam 20 mg
Number of subjects: 60
Study 2744064 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 60
Study 628532 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin (20 units NPH and 10 units regular) and diabetic diet
Number of subjects: 72
Study 628532 — intervention group
Group type: COMPARATOR
Intervention: Diet alone
Number of subjects: 72
Study 628532 — intervention group
Group type: COMPARATOR
Intervention: Neither diet nor insulin
Number of subjects: 72
Study 29385429 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombo-embolic event (stroke or systemic embolism)
Number of subjects: 365
Study 27502812 — intervention group
Group type: EXPERIMENTAL
Intervention: Chair-yoga exercises (CY, n = 20)
Number of subjects: 35
Study 27502812 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG, n = 15)
Number of subjects: 35
Study 25454802 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 mg eszopiclone
Number of subjects: 39
Study 25454802 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study 25454802 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 39
Study 23126214 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg diclofenac p.o. one hour prior to surgery
Number of subjects: 0
Study 23126214 — intervention group
Group type: COMPARATOR
Intervention: Surgical site infiltration with lidocaine and epinephrine
Number of subjects: 0
Study 20974511 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote ischemic preconditioning (RIPC)
Number of subjects: 78
Study 20974511 — intervention group
Group type: COMPARATOR
Intervention: Control (uninflated cuff for 30 minutes)
Number of subjects: 78
Study 18593060 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous magnesium sulfate (4g)
Number of subjects: 18
Study 18593060 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 18
Study 16189981 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-supported breastfeeding promotion
Number of subjects: 0
Study 12200953 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium nitroprusside-induced hypotension (mean arterial pressure lowered to approximately 50 mmHg)
Number of subjects: 30
Study 12200953 — intervention group
Group type: COMPARATOR
Intervention: Control group (no hypotension, mean arterial pressure kept > 70 mmHg)
Number of subjects: 30
Study 12200953 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (hypotensive and control)
Number of subjects: 30
Study 10795554 — intervention group
Group type: EXPERIMENTAL
Intervention: iopromid (low‐osmolar non‐ionic contrast agent)
Number of subjects: 40
Study 10795554 — intervention group
Group type: COMPARATOR
Intervention: iotrolan (blood‐isotone non‐ionic product)
Number of subjects: 40
Study 10795554 — intervention group
Group type: EXPERIMENTAL
Intervention: iopromid
Number of subjects: 40
Study 10795554 — intervention group
Group type: COMPARATOR
Intervention: iotrolan
Number of subjects: 40
Study 8667132 — intervention group
Group type: EXPERIMENTAL
Intervention: Etodolac (300 mg capsules, 2 taken 30 minutes prior to surgery, redosed prn)
Number of subjects: 24
Study 8667132 — intervention group
Group type: COMPARATOR
Intervention: Combination of acetaminophen with hydrocodone (not premedicated, prn regimen)
Number of subjects: 24
Study 8667132 — intervention group
Group type: EXPERIMENTAL
Intervention: Both regimens
Number of subjects: 24
Study 1653901 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg of morphine intraarticularly and saline intravenously (Group 1)
Number of subjects: 52
Study 1653901 — intervention group
Group type: COMPARATOR
Intervention: Saline intraarticularly and 1 mg of morphine intravenously (Group 2)
Number of subjects: 52
Study 1653901 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg of morphine intraarticularly and saline intravenously (Group 3)
Number of subjects: 52
Study 1653901 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg of morphine and 0.1 mg of naloxone intraarticularly and saline intravenously (Group 4)
Number of subjects: 52
Study 6687805 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal anaesthesia with amethocaine 12‐14 mg plus morphine 1 mg (group II)
Number of subjects: 24
Study 6687805 — intervention group
Group type: COMPARATOR
Intervention: Spinal anaesthesia with amethocaine 12‐14 mg (group I)
Number of subjects: 24
Study 30400726 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous infusion of pantoprazole
Number of subjects: 401
Study 30400726 — intervention group
Group type: COMPARATOR
Intervention: Intermittent dosing with pantoprazole
Number of subjects: 401
Study 29523124 — intervention group
Group type: EXPERIMENTAL
Intervention: Dream School Program (DSP) and Mental Health Support Team (MHST)
Number of subjects: 17